Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy Webb TR; Slavish J; George RE; Look AT; Xue L; Jiang Q; Cui X; Rentrop WB; Morris SWExpert Rev Anticancer Ther 2009[Mar]; 9 (3): 331-56Anaplastic lymphoma kinase (ALK), a receptor tyrosine kinase in the insulin receptor superfamily, was initially identified in constitutively activated oncogenic fusion forms - the most common being nucleophosmin-ALK - in anaplastic large-cell lymphomas, and subsequent studies have identified ALK fusions in diffuse large B-cell lymphomas, systemic histiocytosis, inflammatory myofibroblastic tumors, esophageal squamous cell carcinomas and non-small-cell lung carcinomas. More recently, genomic DNA amplification and protein overexpression, as well as activating point mutations, of ALK have been described in neuroblastomas. In addition to those cancers for which a causative role for aberrant ALK activity is well validated, more circumstantial links implicate the full-length, normal ALK receptor in the genesis of other malignancies - including glioblastoma and breast cancer - via a mechanism of receptor activation involving autocrine and/or paracrine growth loops with the reported ALK ligands, pleiotrophin and midkine. This review summarizes normal ALK biology, the confirmed and putative roles of ALK in the development of human cancers and efforts to target ALK using small-molecule kinase inhibitors.|Anaplastic Lymphoma Kinase[MESH]|Animals[MESH]|Antineoplastic Agents/chemistry/*therapeutic use[MESH]|Carrier Proteins/metabolism[MESH]|Cytokines/metabolism[MESH]|Enzyme Inhibitors/chemistry/*therapeutic use[MESH]|Humans[MESH]|Midkine[MESH]|Neoplasms/*drug therapy/enzymology/pathology[MESH]|Nuclear Proteins/metabolism[MESH]|Nucleophosmin[MESH]|Protein-Tyrosine Kinases/*antagonists & inhibitors/genetics/metabolism[MESH]|Receptor Protein-Tyrosine Kinases[MESH] |